FDA OKs Drug for Rare Lipid Disorder

(MedPage Today) -- The FDA has approved lomitapide (Juxtapid) as add-on therapy in patients with a genetic form of hypercholesterolemia. via MedPageToday.com - medical news plus CME for physicians Read More Here..